/

Companies / Anagin

Anagin

United States

Anagin is developing novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases.

Anagin, based in United States, has 1 investor on file, among them EcoR1 Capital. Its site was last checked 6 Nov 2026: site answers.

Investors

1 investor on file
InvestorEvidenceType
EcoR1 CapitalPortfolio pageVenture capital

More from EcoR1 Capital

19 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

See EcoR1 Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Anagin and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when EcoR1 Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/anagin.com/investors

# also
GET /v1/companies/anagin.com
GET /v1/companies/anagin.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing